Chen R - Search Results

1

Percent free prostate-specific antigen is effective to predict prostate biopsy outcome in Chinese men with prostate-specific antigen between 10.1 and 20.0 ng ml(-1).

Chen R, Zhou LQ, Cai XB, Xie LP, Huang YR, He DL, Gao X, Xu CL, Ding Q, Wei Q, Yin CJ, Ren SC, Wang FB, Tian Y, Sun ZQ, Fu Q, Ma LL, Zheng JH, Ye ZQ, Ye DW, Xu DF, Hou JQ, Xu KX, Yuan JL, Gao X, Liu CX, Pan TJ, Sun YH; Chinese Prostate Cancer Consortium. Chen R, et al. Asian J Androl. 2015 Nov-Dec;17(6):1017-21. doi: 10.4103/1008-682X.150846. Asian J Androl. 2015. PMID: 25926603 Free PMC article.

2

Histone methyltransferase SETDB1 is required for prostate cancer cell proliferation, migration and invasion.

Sun Y, Wei M, Ren SC, Chen R, Xu WD, Wang FB, Lu J, Shen J, Yu YW, Hou JG, Xu CL, Huang JT, Sun YH. Sun Y, et al. Among authors: chen r. Asian J Androl. 2014 Mar-Apr;16(2):319-24. doi: 10.4103/1008-682X.122812. Asian J Androl. 2014. PMID: 24556744 Free PMC article.

3

A novel urinary long non-coding RNA transcript improves diagnostic accuracy in patients undergoing prostate biopsy.

Zhang W, Ren SC, Shi XL, Liu YW, Zhu YS, Jing TL, Wang FB, Chen R, Xu CL, Wang HQ, Wang HF, Wang Y, Liu B, Li YM, Fang ZY, Guo F, Lu X, Shen D, Gao X, Hou JG, Sun YH. Zhang W, et al. Among authors: chen r. Prostate. 2015 May;75(6):653-61. doi: 10.1002/pros.22949. Epub 2015 Jan 18. Prostate. 2015. PMID: 25597901

4

Clinical utility of a novel urine-based gene fusion TTTY15-USP9Y in predicting prostate biopsy outcome.

Zhu Y, Ren S, Jing T, Cai X, Liu Y, Wang F, Zhang W, Shi X, Chen R, Shen J, Lu J, Xu C, Wang H, Wang H, Wang Y, Liu B, Li Y, Fang Z, Guo F, Qiao M, Shen D, Lu X, Gao X, Hou J, Sun Y. Zhu Y, et al. Among authors: chen r. Urol Oncol. 2015 Sep;33(9):384.e9-20. doi: 10.1016/j.urolonc.2015.01.019. Epub 2015 May 23. Urol Oncol. 2015. PMID: 26008593

5

Age-Specific Cutoff Value for the Application of Percent Free Prostate-Specific Antigen (PSA) in Chinese Men with Serum PSA Levels of 4.0-10.0 ng/ml.

Chen R, Huang Y, Cai X, Xie L, He D, Zhou L, Xu C, Gao X, Ren S, Wang F, Ma L, Wei Q, Yin C, Tian Y, Sun Z, Fu Q, Ding Q, Zheng J, Ye Z, Ye D, Xu D, Hou J, Xu K, Yuan J, Gao X, Liu C, Pan T, Sun Y; Chinese Prostate Cancer Consortium. Chen R, et al. PLoS One. 2015 Jun 19;10(6):e0130308. doi: 10.1371/journal.pone.0130308. eCollection 2015. PLoS One. 2015. PMID: 26091007 Free PMC article.

6

Prostate cancer antigen 3 moderately improves diagnostic accuracy in Chinese patients undergoing first prostate biopsy.

Wang FB, Chen R, Ren SC, Shi XL, Zhu YS, Zhang W, Jing TL, Zhang C, Gao X, Hou JG, Xu CL, Sun YH. Wang FB, et al. Among authors: chen r. Asian J Androl. 2017 Mar-Apr;19(2):238-243. doi: 10.4103/1008-682X.167715. Asian J Androl. 2017. PMID: 26780868 Free PMC article.

7

Nomograms for predicting Gleason upgrading in a contemporary Chinese cohort receiving radical prostatectomy after extended prostate biopsy: development and internal validation.

He B, Chen R, Gao X, Ren S, Yang B, Hou J, Wang L, Yang Q, Zhou T, Zhao L, Xu C, Sun Y. He B, et al. Among authors: chen r. Oncotarget. 2016 Mar 29;7(13):17275-85. doi: 10.18632/oncotarget.7787. Oncotarget. 2016. PMID: 26943768 Free PMC article.

8

Development and external multicenter validation of Chinese Prostate Cancer Consortium prostate cancer risk calculator for initial prostate biopsy.

Chen R, Xie L, Xue W, Ye Z, Ma L, Gao X, Ren S, Wang F, Zhao L, Xu C, Sun Y; Chinese Prostate Cancer Consortium. Chen R, et al. Urol Oncol. 2016 Sep;34(9):416.e1-7. doi: 10.1016/j.urolonc.2016.04.004. Epub 2016 May 12. Urol Oncol. 2016. PMID: 27185342

9

Prostate Specific Antigen and Prostate Cancer in Chinese Men Undergoing Initial Prostate Biopsies Compared with Western Cohorts.

Chen R, Sjoberg DD, Huang Y, Xie L, Zhou L, He D, Vickers AJ, Sun Y; Chinese Prostate Cancer Consortium; Prostate Biopsy Collaborative Group. Chen R, et al. J Urol. 2017 Jan;197(1):90-96. doi: 10.1016/j.juro.2016.08.103. Epub 2016 Sep 2. J Urol. 2017. PMID: 27593477 Free PMC article.

10

Peripheral zone volume ratio (PZ-ratio) is relevant with biopsy results and can increase the accuracy of current diagnostic modality.

Chang Y, Chen R, Yang Q, Gao X, Xu C, Lu J, Sun Y. Chang Y, et al. Among authors: chen r. Oncotarget. 2017 May 23;8(21):34836-34843. doi: 10.18632/oncotarget.16753. Oncotarget. 2017. PMID: 28422738 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24,950 results

Search Page

Filters